MEDVi vs SkinnyRx: GLP-1 Program Comparison 2026

Bottom line: SkinnyRx wins on price. MEDVi wins on clinical depth. SkinnyRx is one of the more affordable compounded GLP-1 options available, making it attractive for budget-conscious patients who want straightforward medication access without extras. MEDVi charges more but bundles thorough lab work and physician-led consultations that go deeper than what most discount platforms offer. If cost is your top concern and you're otherwise healthy, SkinnyRx gets the job done. If you want more medical oversight and metabolic tracking, MEDVi justifies the higher price.

Quick Comparison

Pricing Breakdown

SkinnyRx positions itself as a value option in the compounded GLP-1 market. Monthly plans start around $149 for lower-dose compounded semaglutide, with tirzepatide options running up to about $299. MEDVi starts at $249 and can reach $399 for higher-tier plans.

The price gap is real, but it reflects different service levels. MEDVi's pricing includes thorough metabolic bloodwork that would cost $200-$400 if ordered independently through a lab. SkinnyRx typically doesn't include lab work, which means you either skip it (not ideal for health monitoring) or pay for it separately through your own doctor.

For a healthy patient who has a primary care doctor already managing routine labs, SkinnyRx's lower price makes sense. For a patient who needs or wants metabolic panels as part of their weight loss program, MEDVi's bundled approach may actually be the better value despite the higher sticker price.

Medications Available

Both platforms offer compounded semaglutide and tirzepatide. Neither provides brand-name GLP-1 medications. The medications themselves are functionally similar, sourced from licensed compounding pharmacies.

The difference is in how dosing and titration are managed. MEDVi follows a more structured titration protocol, with physician-guided dose escalation based on tolerance, side effects, and weight loss progress. SkinnyRx offers standard titration guidance, but the level of hands-on management tends to be lighter.

For patients new to GLP-1 therapy who want more guidance on finding side effects (nausea, appetite changes, injection technique), MEDVi's more involved approach has value. For patients who have taken GLP-1 medications before and know what to expect, SkinnyRx's simplified process is efficient and sufficient.

Patient Experience

Neither platform offers a standout digital experience. Both use functional patient portals that handle the importants: messaging, prescription management, and appointment scheduling. Neither app is on par with larger platforms like Hims or Ro.

MEDVi's onboarding process is more thorough. Expect longer intake questionnaires, more detailed medical history review, and a more in-depth initial consultation. SkinnyRx's onboarding is faster and more simplified, which some patients find refreshing and others find insufficient.

For ongoing check-ins, MEDVi offers scheduled follow-ups with more clinical depth. SkinnyRx follow-ups tend to be brief check-ins focused on refill coordination and basic progress monitoring.

Provider Quality and Support

MEDVi uses board-certified physicians for consultations. SkinnyRx employs a mix of licensed providers including NPs and PAs. Both are qualified to prescribe and manage GLP-1 medications.

The practical difference is in the depth of engagement. MEDVi providers spend more time per consultation and are more likely to discuss lifestyle factors, metabolic biomarkers, and long-term strategy. SkinnyRx providers focus more narrowly on medication management, which keeps things efficient but can feel transactional.

Support responsiveness is comparable, with both platforms operating primarily during business hours via messaging.

Pros and Cons

MEDVi

Pros:

• Physician-led consultations with clinical depth
• thorough lab work included
• Structured dose titration protocols
• More personalized care approach

Cons:

• Significantly higher monthly cost
• Basic digital platform
• May include services some patients don't need
• Slower onboarding due to thorough intake

SkinnyRx

Pros:

• Lower monthly pricing
• Fast, simplified onboarding
• Straightforward medication access
• Good option for experienced GLP-1 patients

Cons:

• Lab work not included
• Less clinical depth in consultations
• Provider interactions can feel brief
• Smaller state coverage
• Limited refund options

Who Should Choose MEDVi

MEDVi is the right choice for patients who are new to GLP-1 therapy, have comorbidities that need monitoring, or want thorough metabolic tracking integrated into their weight loss program. The higher cost pays for clinical infrastructure that budget platforms don't provide.

Who Should Choose SkinnyRx

SkinnyRx makes sense for healthy patients who want affordable access to compounded GLP-1 medication without paying for services they don't need. If you have experience with these medications, have a separate doctor managing your health, and want to minimize monthly costs, SkinnyRx delivers what it promises at a fair price.

How FormBlends Compares

FormBlends offers the physician-supervised clinical depth of MEDVi with a broader treatment toolkit. Beyond GLP-1 weight loss medication, FormBlends provides peptide wellness therapy for recovery, energy, and metabolic support. Every patient works with a licensed physician, and the platform is designed for patients who want more than just a prescription. For those who want a single provider managing both weight loss and broader wellness improvement, FormBlends.com offers an approach worth considering.

What MEDVi and SkinnyRx actually charge right now (September 2026 price index)

The prices quoted in the sections above were checked when this comparison was written. The table below is different: it is pulled from the FormBlends Compounded GLP-1 Price Index, which records the all-in cash price for a 28-day supply from each provider's public pricing page every week. These are the rows for MEDVi and SkinnyRx as of September 3, 2026. Month one is the starting dose (2.5 mg tirzepatide or 0.25 mg semaglutide); month four is the first maintenance step (5 mg or 1 mg).

For context, the index median for compounded tirzepatide at month one was $299 across 14 providers on September 3, 2026, and $197 for compounded semaglutide. Brand Zepbound through LillyDirect was $299 to $449 and the Wegovy pen $199 for the first two fills, then $349. The full dataset, methodology and a CSV download are at the Compounded GLP-1 Price Index, where FormBlends is listed under the same rules as every other provider.

Frequently Asked Questions

Is SkinnyRx safe?

SkinnyRx works with licensed providers and licensed compounding pharmacies. The medications are legally prescribed and dispensed. But the lighter clinical oversight compared to platforms like MEDVi means you should ideally have a primary care doctor monitoring your overall health while using a service like SkinnyRx.

Does MEDVi's lab work replace my regular doctor visits?

No. MEDVi's metabolic panels are focused on weight loss and metabolic health markers. They don't replace thorough annual physicals or screenings your primary care doctor would order. Think of them as an addition, not a replacement.

Can I switch from SkinnyRx to MEDVi mid-treatment?

Yes. You can switch platforms at any time. You'll need to complete MEDVi's intake process, but your existing GLP-1 treatment history will inform their prescribing decisions. There's no need to restart from scratch medically.

Do either platform offer weight loss beyond GLP-1 medications?

MEDVi focuses on metabolic health improvement alongside GLP-1 therapy, including nutritional guidance. SkinnyRx is primarily a medication access platform. Neither offers the breadth of wellness services available through platforms like FormBlends.

Want physician-supervised GLP-1 therapy plus peptide wellness options? See what FormBlends offers and decide if it matches your goals.